WHAT IF EVERY DECISION CREATED LASTING VALUE?

Every purchasing decision in health care shapes not only budgets and operational efficiency but also patient outcomes. Yet, hospitals today face a growing challenge: How to achieve a balance between budget pressures and the delivery of high-quality care.

That’s where value-based health care comes in — ensuring that better patient outcomes and financial sustainability go hand in hand. Gore works with hospitals to help bring this vision closer to reality, offering solutions designed to improve care while supporting cost and efficiency goals.

People meeting

What if every decision you made created value that lasts - for patients, for budgets, for the future?

    Better patient care at lower costs — how hospitals can make informed decisions

    In today’s health care environment, purchasing decisions contribute to shape patient care, operational efficiency and long-term sustainability. Yet, hospitals face increasing pressure to balance costs, operational demands and clinical outcomes — making informed procurement choices more critical than ever.

    Gore helps address these challenges by going beyond the supply of innovative medical devices, offering solutions that can create lasting value for hospital administrators, physicians and patients.

     

    Gore’s value creation pillars:

     

    /Improved outcomes
    human-body-white

    Better patient care and resource efficiency — why hospital decisions matter.

    Hospitals often face ongoing pressure to improve patient outcomes while maintaining financial stability.

    Our products are meticulously designed for lasting performance, that may lead to shorter hospital stays and fewer complications possibly requiring reinterventions.1-10

    Doctor and patient talking

     

    The following examples illustrate how Gore’s innovations can make a measurable difference:

     

    Improving patient outcomes is a priority, but hospitals also face growing financial pressures. Reducing costs without compromising care is just as critical to ensuring sustainable health care delivery.

     

    Efficient care starts here
    /Reduced costs
    lowering-costs-white

    Hospitals are under pressure to cut costs — without compromising care

    Balancing financial sustainability and high-quality patient care is one of the biggest challenges hospitals face today. Due to rising costs, increasing patient numbers and limited resources, finding solutions that enhance operational efficiency and improve clinical outcomes is critical.

    Gore’s innovations can help hospitals reduce costs by minimizing reinterventions, shortening hospital stays and streamlining procurement through effective supply chain solutions:

    Operational efficiency alone isn’t enough — hospitals also need strong expertise and the right support to facilitate procurement decisions and align investments with clinical needs.

     

    Efficiency beyond products
    /Support
    thinking-white

    Improved care begins with thoughtful decisions — not just quality products.

    Gore is more than a supplier — we are a trusted partner in helping hospitals make data-driven decisions that improve both patient care and financial performance.

    Tailored training programs:

    With workshops, symposia and clinical training spanning various skill levels and learning styles, Gore provides extensive resources to help support operational excellence.

    Expert-driven decision-making support:

    Through advice-sharing, peer-to-peer panels, networking, forums and hands-on experiences, Gore offers learning opportunities designed to help achieve a positive patient outcome.

    Pre-case planning and device selection:

    With pre-case planning, including film reading and device sizing for routine and complex cases, Gore can help to streamline processes while maintaining data privacy. Take advantage of information from our Associates on device selection and suitability, even if our informed advice means choosing another med-device brand.

    By investing in your team’s expertise and decision-making skills, Gore strives to support hospitals in delivering quality care with a focus on financial sustainability.

    Doctors

    Decisions to create lasting value — for patients, physicians, procurement and hospitals.

    /Partnership

    Collaborative partnership can help hospitals drive operational success – we are here to support you.

    Beyond training and expert guidance, hospitals need a partner they can count on for long-term stability. Gore provides more than just support — we strive to provide a reliable supply, regulatory compliance and a commitment to sustainable health care.

     

    Reliable

    Reliable Supply

    Seamless product availability through robust supply chain management. Over the past 2 yearsb, we have successfully shipped 99.98% of orders on the same day, while maintaining a 99.95% order accuracy rate.

    certificates-red

    Regulatory compliance

    Committed to patient safety, we achieved compliance with the EU's Medical Device Regulation (MDR) program in August 2021, with all Gore devicesc MDR certified by May 2023.

    Sustainable

    Sustainable health care

    Commitment to responsible manufacturing and longterm health care impact.

    handshake-red

    Efficient Procurement

    We are offering dependable manufacturing, real-time inventory management and electronic purchasing. Trust Gore to deliver the right products at the right time, enabling you to focus on patient care.

    a Gore Global Registry for Endovascular Aortic Treatment (GREAT Registry) N = 3,274. To calculate the overall event rates from procedure through end of study period, all subjects who could have had events, regardless of length of follow-up, were included. For outcome data, GREAT Registry only collects site reported serious adverse events.
    b Past 2 years: 2023-2025
    c Part of Gore's MDR program

    1. Iqbal K, Schumann E. Cost-consequence analysis of EPTFE vascular grafts with heparin end point covalent bond compared to standard EPTFE vascular grafts in below-knee surgical bypass for critical limb ischemia pad patients in Germany. Presented at ISPOR Europe (International Society for Pharmacoeconomics and Outcomes); November 6-9, 2022; Vienna, Austria. Value in Health 2022;25(12) Supplement:S114. EE306.
    2. Bureau C, Thabut D, Oberti F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 2017;152(1):157-163.
    3. Vergnaud S, Riche VP, Tessier P, Mauduit N, Kaladji A, Gouëffic Y. Budget impact analysis of heparin-bonded polytetrafluoroethylene grafts (Propaten) against standard polytetrafluoroethylene grafts for below-the-knee bypass in patients with critical limb ischaemia in France. BMJ Open 2018;8(2):e017320.
    4. Raithel D, Qu L, Hetzel G. Optimal EVAR fixation: infrarenal fixation is the safest option. Endovascular Today 2005;4(8):62-65.
    5. Stokmans RA, Teijink JA, Forbes TL, et al. Early results from the ENGAGE registry: real-world performance of the Endurant Stent Graft for endovascular AAA repair in 1262 patients. European Journal of Vascular & Endovascular Surgery 2012;44(4):369-375.
    6. Hernández-Gea V, Procopet B, Giráldez Á, et al. International Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology 2019;69(1):282-293.
    7. Gable DR, Verhoeven E, Trimarchi S, et al. GREAT Investigators. Endovascular treatment for thoracic aortic disease from the Global Registry for endovascular aortic treatment. Journal of Vascular Surgery 2024;79(5):11044-1056.e1.
    8. Tjaden BL Jr, Sandhu H, Miller C, et al. Outcomes from the Gore Global Registry for Endovascular Aortic Treatment in patients undergoing thoracic endovascular aortic repair for type B dissection. Journal of Vascular Surgery 2018;68(5):1314-1323.
    9. O’Neill F, Nakum M, Alberta H, Ankeny R, Waltham M. A comparative economic analysis of the GORE® EXCLUDER® AAA Endoprosthesis versus competitive grafts: real world data from two prospective observational multicentre registries. – Presented at the Vascular Societies’ Annual Scientific Meeting; November 24-27, 2020; Virtual. O60.
    10. Gouëffic Y, Favre JP, Steinmetz E, et al. A randomized controlled trial comparing crude versus heparin-bonded PTFE graft in below the knee bypass surgery for critical limb ischemia (REPLACE Trial). Design and protocol. Annals of Vascular Surgery 2019;58:115-121.
    11. Villemoes MK, Lindholt JS, Houlind KC, et al. Cost-effectiveness evaluation of heparin coated versus standard graft for bypass surgery in peripheral artery disease alongside a randomised controlled trial. European Journal of Vascular & Endovascular Surgery 2018;56(1):87-93.
    12. Ferreira RS, Bastos Gonçalves F, Postimplantation syndrome after endovascular aneurysm repair. In: Koncar I, ed. Abdominal Aortic Aneurysm. From Basic Research to Clinical Practice. Limited; London, United Kingdom: IntechOpen 2019;8:1-18. Accessed June 3, 2025. https://www.perlego.com/book/2025450/abdominal-aortic-aneurysm-from-basic-research-to-clinical-practice-pdf
    13. Sultan S, Barrett N, Tawfick W, Parodi JC, Hynes N. Contemporary abdominal aortic aneurysm devices, three decades of research and development with big data. Why has the best graft not been produced yet? A missed opportunity. Italian Journal of Vascular & Endovascular Surgery 2019;26(3):121-134.
    14. Raithel D, Qu L, Hetzel G. Optimal EVAR fixation: infrarenal fixation is the safest option. Endovascular Today 2005:4(8):62-65.
    15. Chinai N, Papworth E, Balasubramaniam K, et al. The impact of preserving pelvic perfusion using iliac branch devices on quality of life. Journal of Vascular Medicine & Surgery 2017;5(5):344
    16. Verzini F. Comparing the various industry-made iliac branch devices (IBDs) for treating common and internal illac aneurysms: advantages and limitations of each: when to use which one. Presented at the 46" Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposlum): November 19 -23, 2019; New York, NY. https://archive.veithsymposium.org/abstracts/2019/vei/499.pdf.
    17. Brown J, Gorman J, Sondreaal M, Powis S. Evaluation of the GORE®TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Descending Thoracic Aorta (Pivotal): Zone 2. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2021. [Pre-Market Approval Study Report]. MD185099. Rev 1.
    18. Squiers JJ, DiMaio JM, Schaffer JM, et al. Surgical debranching versus branched endografting in zone 2 thoracic endovascular aortic repair. Journal of Vascular Surgery 2022;75(6):1829-1836.e3
    19. Iqbal K, Reijnen MM, Holewijn S, van Wijck I. Impact on hospital healthcare resources, comparison of endoluminal versus surgical treatment strategies for lower limb bypass in PAD patients. Presented at ISPOR Europe (International Society for Pharmacoeconomics and Outcomes); November 6-9, 2022; Vienna, Austria. Value in Health 2022;25(12)Supplement:S59. EE33.

    Gore information for health care providers that are involved in the purchasing of medical devices

     

    IFU Consult instructions

    Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RxOnly

    Product may not be available in all countries. Please check with your Gore representative for availability.
    25PR2022-EN01

    Contact us to learn more about what we can do for you as a health care provider